Adagio Medical Inc.

0.81
0.04 (5.63%)
At close: Apr 14, 2025, 3:49 PM
0.77
-4.52%
Pre-market: Apr 15, 2025, 04:06 AM EDT

Adagio Medical Statistics

Share Statistics

Adagio Medical has 15.38M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding 15.38M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Institutions (%) n/a
Shares Floating -
Failed to Deliver (FTD) Shares 617
FTD / Avg. Volume 0.47%

Short Selling Information

The latest short interest is 11.54K, so 0.08% of the outstanding shares have been sold short.

Short Interest 11.54K
Short % of Shares Out 0.08%
Short % of Float 0.08%
Short Ratio (days to cover) 0.85

Valuation Ratios

The PE ratio is -0.28 and the forward PE ratio is null. Adagio Medical's PEG ratio is 0.

PE Ratio -0.28
Forward PE n/a
PS Ratio 56.74
Forward PS null
PB Ratio 0.77
P/FCF Ratio -0.93
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Adagio Medical.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.82.

Current Ratio 3.27
Quick Ratio 2.93
Debt / Equity 0.82
Debt / EBITDA -0.26
Debt / FCF -0.99
Interest Coverage 56.54

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $3.36K
Profits Per Employee $-672.04K
Employee Count 80
Asset Turnover 0.01
Inventory Turnover 0.75

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0.19, so Adagio Medical's price volatility has been higher than the market average.

Beta 0.19
52-Week Price Change null%
50-Day Moving Average 1.04
200-Day Moving Average null
Relative Strength Index (RSI) 43.27
Average Volume (20 Days) 131.87K

Income Statement

In the last 12 months, Adagio Medical had revenue of 269K and earned -53.76M in profits. Earnings per share was -3.7.

Revenue 269K
Gross Profit -1.67M
Operating Income -62.48M
Net Income -53.76M
EBITDA -62.48M
EBIT -54.87M
Earnings Per Share (EPS) -3.7
Full Income Statement

Balance Sheet

The company has 20.59M in cash and 16.27M in debt, giving a net cash position of 4.32M.

Cash & Cash Equivalents 20.59M
Total Debt 16.27M
Net Cash 4.32M
Retained Earnings -70.59M
Total Assets 107.2M
Working Capital 27.11M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.99M and capital expenditures -368K, giving a free cash flow of -16.36M.

Operating Cash Flow -15.99M
Capital Expenditures -368K
Free Cash Flow -16.36M
FCF Per Share -1.13
Full Cash Flow Statement

Margins

Gross margin is -620.07%, with operating and profit margins of -23226.77% and -19986.25%.

Gross Margin -620.07%
Operating Margin -23226.77%
Pretax Margin -19986.25%
Profit Margin -19986.25%
EBITDA Margin -23226.77%
EBIT Margin -23226.77%
FCF Margin -6081.04%

Dividends & Yields

ADGM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ADGM.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -0.19
Piotroski F-Score 2